Dechert Survey of Securities Fraud Class Actions Brought Against Life Sciences Companies

March 20, 2012

This survey examines trends in securities fraud lawsuits filed against life sciences companies as well as significant recent developments in this area of law and their potential impact on what the future may hold for life sciences companies in the securities fraud arena as well as steps that companies can take to minimize the risk of, or impact from, securities fraud class action lawsuits.

Read more.

Subscribe to Dechert Updates